Farnesoid X receptor mediates hepatic steatosis induced by PM2.5

被引:0
|
作者
Mengyao Wang
Jieqiong Tan
Ji Zhou
Bin Yi
Zhijun Huang
机构
[1] Central South University,Center for Clinical Pharmacology, The Third Xiangya Hospital
[2] Central South University,Center for Medical Genetics, Life Science School
[3] Shanghai Key Laboratory of Meteorology and Health,Typhoon Institute/CMA
[4] Central South University,Department of Nephrology, The Third Xiangya Hospital
来源
Environmental Science and Pollution Research | 2020年 / 27卷
关键词
PM; Farnesoid X receptor; Hepatic steatosis; Nuclear receptor; Air pollution; Fatty liver;
D O I
暂无
中图分类号
学科分类号
摘要
Ambient particulate matter (PM) newly has been regarded as a conceivable hazard for public health. A large number of studies have described that PM, exceptionally PM2.5, is correlated with respiratory, cardiovascular, and metabolic diseases, etc. PM2.5-induced hepatocyte steatosis previously has been uncovered both in cellular and murine models. Nevertheless, less is known about the underlying mechanism. Here, we found that PM2.5 could cause the downregulation of farnesoid X receptor (FXR), a key transcription factor for lipid metabolism. FXR could regulate the accumulation of lipid droplets induced by PM2.5 in vitro. Moreover, FXR−/− mice were exposed to PM2.5 for 2 months to investigate the role of FXR in pathogenesis of PM2.5-induced hepatic steatosis in vivo. The results showed that exposure of wild-type (WT) mice to PM2.5 caused mild liver steatosis compared with the mice exposure to filtered air (FA). Furthermore, the content of triglyceride (TG) and total cholesterol (TC) was elevated in WT mice liver triggered by the inhalation of PM2.5. However, there was no statistical difference in TG and TC content between FXR−/− mice with and without PM2.5 exposure. Overall, our finding suggested FXR mediated PM2.5-induced hepatic steatosis.
引用
收藏
页码:34412 / 34420
页数:8
相关论文
共 50 条
  • [31] Comparative receptor modeling study of PM10 and PM2.5 in Seoul, Korea
    Kim, YS
    Lee, JT
    Kim, H
    Cho, YS
    Lee, HS
    Kim, SY
    EPIDEMIOLOGY, 2002, 13 (04) : S235 - S235
  • [32] Statin Attenuated Myocardial Inflammation Induced by PM2.5 in Rats
    Yao, Hongmei
    Lv, Jiyuan
    ACTA CARDIOLOGICA SINICA, 2017, 33 (06) : 637 - 645
  • [33] Farnesoid X Receptor Regulates Glutamate Metabolism: Relevance for Hepatic Encephalopathy
    Renga, Barbara
    Migliorati, Marco
    Mencarelli, Andrea
    Cipriani, Sabrina
    Distrutti, Eleonora
    Palladino, Giuseppe
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2010, 138 (05) : S791 - S791
  • [34] PM2.5 Source Apportionment Based on a Variety of New Receptor Models
    Wang Z.-Y.
    Li Y.-B.
    Guo L.
    Song Z.-Q.
    Xu Y.-L.
    Wang F.
    Liang W.-Q.
    Shi G.-L.
    Feng Y.-C.
    Huanjing Kexue/Environmental Science, 2022, 43 (02): : 608 - 618
  • [35] Source apportionment of phoenix PM2.5 aerosol with the Unmix receptor model
    Lewis, CW
    Norris, GA
    Conner, TL
    Henry, RC
    JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION, 2003, 53 (03): : 325 - 338
  • [36] Farnesoid X receptor represses hepatic human APOA gene expression
    Chennamsetty, Indumathi
    Claudel, Thierry
    Kostner, Karam M.
    Baghdasaryan, Anna
    Kratky, Dagmar
    Levak-Frank, Sanja
    Frank, Sasa
    Gonzalez, Frank J.
    Trauner, Michael
    Kostner, Gert M.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09): : 3724 - 3734
  • [37] Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
    Claudel, T
    Inoue, Y
    Barbier, O
    Duran-Sandoval, D
    Kosykh, V
    Fruchart, J
    Fruchart, JC
    Gonzalez, FJ
    Staels, B
    GASTROENTEROLOGY, 2003, 125 (02) : 544 - 555
  • [38] Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
    Yang Jiao
    Yan Lu
    Xiao-ying Li
    Acta Pharmacologica Sinica, 2015, 36 : 44 - 50
  • [39] Pentraxin 3 mediates early inflammatory response and EMT process in human tubule epithelial cells induced by PM2.5
    Lin, Chien-Hung
    Liu, Wen-Sheng
    Wan, Chuan
    Wang, Hsin-Hui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [40] Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates
    Amano, Yuichiro
    Shimada, Mitsuyuki
    Miura, Shotaro
    Adachi, Ryutaro
    Tozawa, Ryuichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 108 - 115